Medicine News and Research

RSS

Sick leave eligibility rules in the U.S. widen racial inequalities in the labor market, finds study

Paid sick leave is one of the most powerful tools for preventing the spread of COVID-19 and other infectious diseases and ensuring all workers can access treatment - yet tens of millions of workers across the U.S. lack coverage.

26 Jul 2021

Mount Sinai researchers use cerebral organoids to study frontotemporal dementia

Frontotemporal dementias are a group of fatal and debilitating brain disorders for which there are no cures.

26 Jul 2021

More popular type of antihypertensive drugs causes slightly more side effects

Two types of drugs that are recommended as a first treatment for patients with high blood pressure were found equally effective in improving cardiovascular outcomes, but the more popular type causes slightly more side effects, finds a multinational observational study led by researchers at Columbia University Vagelos College of Physicians and Surgeons.

26 Jul 2021

Two types of blood pressure drugs provide equal benefits, but side effects differ

People who are just beginning treatment for high blood pressure can benefit equally from two different classes of medicine - angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) - yet ARBs may be less likely to cause medication side effects, according to an analysis of real-world data published today in Hypertension, an American Heart Association journal.

26 Jul 2021

Positive future orientation and strong parental support linked with lower risk of youth vaping

Adolescents who set goals for their future and those with strong parental support are less likely to use e-cigarettes and other tobacco products, according to a study by UPMC Children's Hospital of Pittsburgh and University of Pittsburgh School of Medicine physician-scientists.

26 Jul 2021

Comprehensive genomic sequencing essential to capitalize precision medicine for pediatric cancer care

St. Jude Children's Research Hospital investigators have demonstrated that comprehensive genomic sequencing of all pediatric cancer patients is feasible and essential to capitalize on the lifesaving potential of precision medicine.

26 Jul 2021

Nasal swabs reveal muted antiviral response in patients who developed severe COVID-19

Over the past 18 months, researchers have learned much about COVID-19 and its viral cause, SARS-CoV-2. They know how the virus enters the body, coming in through the nose and mouth and beginning its infection in the mucus layers of the nasal passageway.

26 Jul 2021

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions of the virus.

26 Jul 2021

Researchers develop ovarian tumor microenvironment-chip to test novel ways to treat the disease

In the evolving field of cancer biology and treatment, innovations in organ-on-a-chip microdevices allow researchers to discover more about the disease outside the human body.

23 Jul 2021

Novel therapeutic agent could be effective for treating cancers with certain gene mutations

Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.

23 Jul 2021

Study reflects shortcomings in how the U.S. handles care for people with opioid addiction

As opioid overdose deaths rose during the COVID-19 pandemic, people seeking treatment for opioid addiction had to wait nearly twice as long to begin methadone treatment in the United States than in Canada, a new Yale study has shown.

23 Jul 2021

Gene therapy protects optic nerve cells and preserves vision in glaucoma mouse models

A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH's National Eye Institute.

23 Jul 2021

Proportion of incorrectly established paternities has decreased over time, study finds

Determining who is the biological father of a child is a sensitive subject, but the answer can be crucial in important issues.

23 Jul 2021

Researchers identify four themes as key contributors to diseases of despair in Pennsylvania

Financial instability, lack of infrastructure, a deteriorating sense of community and family fragmentation are key contributors to diseases of despair in Pennsylvania communities, according to Penn State College of Medicine and Highmark Health researchers.

23 Jul 2021

Study receives $15 million CDC award to continue research on COVID-19 immunity, vaccine effectiveness

A University of Arizona Health Sciences study of COVID-19 vaccine effectiveness and immunity among frontline workers has received a $15 million award from the U.S. Centers for Disease Control and Prevention (CDC) to continue the current research for another year and expand to include children and focus on underserved populations.

23 Jul 2021

Yale wins USAID award to advance research utilization in Liberia's health sector

Yale University has received a $15 million, five-year U.S. Agency for International Development (USAID) award to advance research utilization in Liberia's health sector.

23 Jul 2021

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to test the efficacy of Loncastuximab tesirine, a promising new treatment for aggressive B-cell lymphoma.

23 Jul 2021

Brain's "feel good" chemical messenger can be willfully manipulated, study shows

From the thrill of hearing an ice cream truck approaching to the spikes of pleasure while sipping a fine wine, the neurological messenger known as dopamine has been popularly described as the brain's "feel good" chemical related to reward and pleasure.

23 Jul 2021

Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

There are many reasons that an intranasal vaccine against the SARS-CoV-2 virus would be helpful in the fight against COVID-19 infections, University of Alabama at Birmingham immunologists Fran Lund, Ph.D., and Troy Randall, Ph.D., write in a viewpoint article in the journal Science.

23 Jul 2021

Blunted antiviral responses in the nasopharynx may underlie severe COVID-19

The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new study in the journal Cell suggests that the first responses in this battleground help determine who will develop severe disease and who will get through with mild or no illness.

23 Jul 2021

Medicine News and Research

Sick leave eligibility rules in the U.S. widen racial inequalities in the labor market, finds study

Mount Sinai researchers use cerebral organoids to study frontotemporal dementia

More popular type of antihypertensive drugs causes slightly more side effects

Two types of blood pressure drugs provide equal benefits, but side effects differ

Positive future orientation and strong parental support linked with lower risk of youth vaping

Comprehensive genomic sequencing essential to capitalize precision medicine for pediatric cancer care

Nasal swabs reveal muted antiviral response in patients who developed severe COVID-19

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

Researchers develop ovarian tumor microenvironment-chip to test novel ways to treat the disease

Novel therapeutic agent could be effective for treating cancers with certain gene mutations

Study reflects shortcomings in how the U.S. handles care for people with opioid addiction

Gene therapy protects optic nerve cells and preserves vision in glaucoma mouse models

Proportion of incorrectly established paternities has decreased over time, study finds

Researchers identify four themes as key contributors to diseases of despair in Pennsylvania

Study receives $15 million CDC award to continue research on COVID-19 immunity, vaccine effectiveness

Yale wins USAID award to advance research utilization in Liberia's health sector

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

Brain's "feel good" chemical messenger can be willfully manipulated, study shows

Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

Blunted antiviral responses in the nasopharynx may underlie severe COVID-19

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News